A UCLA study identifies a cell therapy that can stop progressive damage and stimulate the brain’s repair processes in mice.
A UCLA-led study also found that hospitals that treat more than 450 people for stroke each year have better outcomes.
A drug that suppresses the gene could lead to the first pill to treat stroke’s aftermath.
Researchers engineered a hydrogel that, when injected into the brain, thickens to create a scaffolding into which blood vessels and neurons can grow.
Highlights from the New York Times, Los Angeles Times, ABC News, Washington Post, NPR, Wired and others.
The unique, high-tech ambulance can deliver time-critical treatment in the field to stroke patients who might otherwise face debilitating delays.
Long term follow-up indicates new treatment option used instead of, or in addition to, medication could benefit certain people who’ve had a stroke.
The injectable hydrogel works by forming a scaffold inside a wound that new tissue can grow around.
The discovery could have important implications for treating white matter strokes, a major cause of dementia that also accelerate Alzheimer’s disease.
UCLA-led study shows that stent retrievers can provide benefits more than seven hours after onset of a stroke.
Finding may have implications for preventing stroke and diagnosing Alzheimer’s disease earlier.
When blood flow was restored to the brain within four hours of the start of a stroke, four of every five patients had a very good outcome.
Using a new stent retriever device in addition to a clot-busting drug led to a significant increase in the percentage of stroke sufferers who could function independently three months later.
Study found that paramedics can give intravenous medications to stroke patients within the “golden hour,” the window during which treatments are most likely to help patients avoid long-term neurological damage.
The UCLA Comprehensive Stroke Center at Ronald Reagan UCLA Medical Center has received the Get With The Guidelines-Stroke Gold-Plus Quality Achievement Award for implementing quality improvement measures.
Jennifer Reilly was 28 years old when she had a stroke. Her UCLA doctors say that quickly seeking medical attention after symptoms emerged likely spared her potentially debilitating consequences.
Researchers saw a jump in patients receiving a crucial clot-dissolving drug within the first 60 minutes after they arrive at a hospital emergency room.
UCLA emergency room staff know that every minute counts when it comes to treating patients who have suffered from a stroke. “Time is brain.”With these words, UCLA professor of emergency medicine and neurology Dr. Sidney Starkman...